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Toward Smart Implant Synthesis: 
Bonding Bioceramics of Different 
Resorbability to Match Bone 
Growth Rates
Rafael Comesaña1, Fernando Lusquiños1, Jesús del Val1, Félix Quintero1, Antonio Riveiro1, 
Mohamed Boutinguiza1, Julian R. Jones2, Robert G. Hill3 & Juan Pou1
Craniofacial reconstructive surgery requires a bioactive bone implant capable to provide a gradual 
resorbability and to adjust to the kinetics of new bone formation during healing. Biomaterials made 
of calcium phosphate or bioactive glasses are currently available, mainly as bone defect fillers, but 
it is still required a versatile processing technique to fabricate composition-gradient bioceramics for 
application as controlled resorption implants. Here it is reported the application of rapid prototyping 
based on laser cladding to produce three-dimensional bioceramic implants comprising of a calcium 
phosphate inner core, with moderate in vitro degradation at physiological pH, surrounded by a 
bioactive glass outer layer of higher degradability. Each component of the implant is validated in 
terms of chemical and physical properties, and absence of toxicity. Pre–osteoblastic cell adhesion 
and proliferation assays reveal the adherence and growth of new bone cells on the material. This 
technique affords implants with gradual-resorbability for restoration of low-load-bearing bone.
The bone tissue regeneration approach involves placing a temporary template into a bone defect that will 
promote cell attachment, proliferation, differentiation, three-dimensional vascularised bone growth, with 
minimal fibrous tissue growth followed by degradation as the bone remodels. This approach is necessary 
in the repair of defects due to traumatic accidents, tumour extraction surgery, or congenital deformities 
correction. The autograft utilization has potential complications and it is not always available in sufficient 
quantity1–3; therefore, synthetic biomaterials are employed for such applications. A further development 
is the use of implants that are tailored to the patient, as schematized in Fig. 1a. Critical size defects are 
not expected to grow back to normal size and shape by themselves, hence they required aid of a bone 
substitution material. The new bone ingrowth rate depends on several factors, such as the defect location, 
the surrounding bone type, the graft material, and the patient age and health. Nevertheless, the tracking 
studies of the healing process reveal a common pattern, showing the most intensive osteogenesis within 
an initial stage, and followed by a remarkable reduction of bone ingrowth rate at medium and long-term 
periods4–6. Patients would benefit from tailored bioactive implants with resorbability capable to match 
the new bone growth rate at different healing stages7–11. Gradual resorption is the main objective in 
order to provide high resorbability and osteoinduction in the first stage after implantation, in addition 
to long-term implant stability8,9,11.
Most calcium phosphate (CaP) bioceramics show very good biocompatibility as well as osteocon-
ductive and osteoinductive capabilities12–14. The ions released during physiological fluid and osteoclast 
mediated dissolution stimulate the expression of different genes related to bone production15–19, but 
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the resorbability frequently differs from the bone ingrowth kinetics20–23. With the aim of increasing 
resorption rates, the development of doped CaPs and the combination of CaP compounds with bioactive 
glasses (BGs) have been assessed24–26. The silica based BGs are osteoconductive and their dissolution 
products up-regulate several important genes related to bone formation27–31. As a result, the effect of the 
BG resorption mediated by the physiological fluids mimics those bone matrix-derived factors released 
during osteoclastic bone resorption in biological remodelling32–34, increasing the preosteoblastic cells 
differentiation and production of new bone. Nevertheless, the in vivo degradation of BGs is too fast to 
allow the required stability for new bone formation at long-term35–37. Processing homogeneous CaP and 
BG mixtures affords ceramics and glass–ceramics composites that exhibit intermediate but, nevertheless, 
spatially homogeneous in vivo degradation38–40. The approach to overcome this limitation is to selectively 
modify the bioceramic in the spatial domain.
Figure 1. Schematic illustration of implant tailored fabrication from defect diagnostics, and of the approach 
followed in this work to attain a progressively resorbed material. (a) Computerized imaging techniques 
provide three-dimensional data of the bone defect, which are employed to design a computer model of 
the required implant, afterward fabricated by a rapid prototyping technique. (b) The outer bioactive glass 
(BG) layer (upper left) of the implant is resorbed within an initial stage by the physiological fluid, favoring 
the precipitation of an osteoconductive HA layer and the differentiation of osteoblast precursors required 
for intensive bone formation. Subsequently, the inner multiphasic CaP is slowly resorbed by mediation of 
osteoclasts and physiological fluid, releasing chemical species that promote bone ingrowth and providing 
stability at long term.
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In this study, we present a new laser-assisted fabrication method for customized bone implants 
designed for patients undergoing reconstructive surgery. The unique implant is composed of a CaP 
modified inner core with moderate degradation rate, and a BG outer layer of higher degradability, as 
explained in Fig. 1b. This technique provides a method to produce gradual resorbability implants for low 
load bearing bone restoration, with capabilities to integrate specific agents inducing antibacterial, angio-
genic, or antiresorptive activity. Laser cladding has already been applied in its bi-dimensional version to 
produce calcium phosphate coatings41–46 and bioactive glass coatings47 on titanium alloys for biomedical 
applications.
Results
The low resorption inner core of the implant was synthesized using highly crystalline stochiometric HA 
as bioceramic precursor. In order to increase the material reactivity, the precursor particles were sub-
jected to powerful laser [wavelength 1064 nm] irradiation sufficient to induce the following reactions: (1) 
debonding of solid state hydroxyl groups from the HA lattice (Ca10(PO4)6(OH)2) leading to the formation 
of oxyapatite (Ca10(PO4)6O2); and (2) partial decomposition of oxyapatite and phase change to a liquid 
phase in the CaO–P2O5 system. The subsequent step in the process involves displacement of the depos-
ited material away from the laser irradiated area and cooling at moderate rates. This step leads to the 
precipitation from the liquid phase of tetracalcium phosphate (TTCP, Ca4(PO4)2O) and alpha-tricalcium 
phosphate (α -TCP, α -Ca3(PO4)2). As a result, the obtained implant presents a unique multiphasic micro-
structure, which keeps the overall material Ca/P ratio and combines highly resorbable CaP phases with 
still-lower-resorbability oxyapatite (Fig. 2a and b). Complete dehydroxylation of the HA particles during 
processing of multilayered samples is demonstrated by Raman and Fourier-transform infrared (FTIR) 
spectroscopy (see supporting information). The flow of injected particles, the absorbed energy density, 
and the coaxial Argon flow govern the thermal cycle experienced by the HA and, therefore, the propor-
tion of molten oxyapatite preceding the formation of α -TCP and TTCP phases. The identification of each 
crystalline phase was performed by micro-Raman and quantitative energy dispersive X-ray spectroscopy 
using CaP standard materials with certified Ca/P ratios (table in Fig. 2).
The generation of an intermediate liquid phase is a key feature of this laser-assisted technique that 
is necessary to obtain fine homogeneous layers. It avoids the requirement of additional binding sub-
stances (which are toxic or reduce bioactivity) to consolidate the CaP according the geometry defined 
in the preoperative evaluation and surgical planning. In addition, the presence of a liquid phase with 
lower surface tension leads to oxyapatite-free surfaces, with implications for implant resorbability and 
bioactive behavior, and particularly for the possibility of chemical reactions during further processing 
with dissimilar bioceramic materials such as silicate BGs. Macroscopic CaP samples are produced by 
stacking a variable number of layers: typically, samples are processed from 20 to 320 stacked layers with 
layer thicknesses between 100 to 300 micrometers and a 100 °C/min cooling rate to preserve the material 
integrity (see Fig. 2a).
To demonstrate the increased degradability in comparison with stoichiometric HA, the ion release 
profiles of the fabricated implants in physiological conditions were tested by immersion in 0.05 M Tris–
HCl buffer. Figure  2c shows that the calcium concentration released by the laser processed material is 
remarkably higher than that released by the precursor HA. The TTCP and metastable α -TCP generated 
by this process present a lower chemical stability under physiological pH than stoichiometric calcium 
HA. Additionally, we demonstrated the non-cytotoxic behavior of the CaP implant cores by means of a 
solvent extraction test and seeding of the pre-osteoblastic line MC3T3-E1 (Fig. 2d). The capacity of bone 
cell precursors to adhere to the inner core during the healing process was assessed by scanning electron 
microscopy. Figure 2e shows that the cells seeded on the culture plates adhered to the material and pro-
liferated over time to cover the surface completely after 7 days. These experiments demonstrate the low 
toxicity of the material, and agree with previous findings stating that TTCP and α -TCP phases are not 
detrimental to proliferation of pre-osteoblastic cells and promote cell differentiation and extra-cellular 
matrix mineralization15. Considering the existing calcium phosphate phases in the implants, it can 
be expected that the implants allow bone cells to develop at their surface during the healing process. 
Another important feature of the laser-engineered implants is that the Ca/P ratio in the samples at the 
few-micrometer scale remains the same as that in the precursor material, which prevents the excessive 
occurrence of harmful intermediate reactions during dissolution and biological apatite precipitation, and 
limits the pH induced change in the environment.
Outer Shell: Laser Cladding of Highly Resorbable Bioactive Glass. In order to produce 
higher-resorbability outer layers, we first investigated the applicability of silicate-based BG microparti-
cles to the process. The precursor particles were injected into the molten pool at high speed, where the 
absorbed laser radiation increased the temperature and melted the particles in several milliseconds. We 
started the process over a Ti6Al4V disposable substrate and it was afterwards self-supported due to the 
immediate increase in glass viscosity as the temperature decreased. As described above for the prepara-
tion of the CaP inner core, the relative movement of the injecting nozzle and laser beam with respect 
to the substrate is controlled to deposit the glass in a layer-by-layer manner. The processing parameters 
are adjusted to maintain the temperature of the deposited BG above the transition temperature for long 
enough to avoid thermal shock. In selecting the precursor glass composition we considered the reported 
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Figure 2. Synthesis and validation of inner core implant material by laser cladding of HA. (a) CaP samples 
produced by rapid prototyping based on laser cladding (laser wavelength: 1064 nm, 50 stacked layers). 
(b) Backscattered electron micrograph of the cross section near the surface showing metastable α -TCP 
matrix surrounding elongated TTCP grains and internal oxyapatite grains. (c) Calcium ion release during 
dissolution in Tris-HCl buffer. (d) MC3T3-E1 proliferation in different dilutions of laser-cladding-processed 
HA extracts (statistical significance p < 0.05; C- pure cell culture medium). (e) SEM images of attachment 
and spreading of the MC3T3-E1 cell line on the laser-cladding-processed sample surfaces (A 1 day, B 3 days, 
C 7 days).
www.nature.com/scientificreports/
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biocompatibility, osteoconductivity, and osteoinductivity in addition to the devitrification tendency and 
viscosity-temperature evolution7,26–28. The 45S5 Bioglass® composition developed by Hench is considered 
a reference in terms of bioactivity. However, this material is prone to devitrification during hot working 
processes48,49 and only very fast processes such as laser spinning are able to preserve the amorphous 
state50. Devitrification can cause instability during dissolution and compromises the mechanical consist-
ency of the implant material due to tensions caused by the density mismatch between the grown crystal-
lites and the parent glass. This leads to an increase in eventual failure probability and even complicates 
implant handling. Therefore, we employed an alternative BG composition, the S520 BG, to avoid the 
above mentioned problem. Crystal growth inhibition by potassium addition allows S520 BG to have a 
smooth viscosity-temperature evolution and a higher working range, combined with the required bioac-
tivity47,51. Thus, we were able to increase the processing window and the implant size while maintaining 
the desired solidity.
The properties of the outer shell material were validated by scanning electron microscopy, cell prolif-
eration assay, and immersion test. Figure 3a shows a layered bioceramic implant produced by irradiation 
of exclusively S520 BG. Nucleation is present via a surface crystallization mechanism, but the crystal 
growth is strongly inhibited, barely reaching a depth of a few microns under the implant surface and 
not compromising the implant function. Comparison of precursor material and processed samples by 
X-ray fluorescence analysis showed differences that were within the intrinsic compositional variability 
of the precursor glass, which supports the preservation of the precursor glass chemical composition. In 
addition, we demonstrated the non-cytotoxic behavior of the laser-processed BG by means of a solvent 
extraction test and seeding of the pre-osteoblastic line MC3T3-E1. Comparative cell proliferation assays 
showed very similar results for laser processed S520 and 45S5 BGs52. The assessment by means of scan-
ning electron microscopy showed the ability of bone precursor cells to adhere to the BG surfaces. In 
the on-sample direct seeding tests, the pre-osteoblastic cells that attached to the implant surface exhib-
ited a healthy morphology and spread over the complete sample surface after seven days of incubation 
(Fig. 3b). Measurements of the osteoblast coverage of surface area show that approximately 60% and 90% 
of surface is covered after 3 and 7 days of incubation time, respectively. The statistical analysis reveals 
that differences of coverage between the samples obtained from 45S5 and S520 BGs are not significant 
(statistical significance p < 0.05).
The ion release profile of calcium and soluble silica from BGs leads to the up-regulation and activation 
of different families of genes in osteoprogenitor cells with important consequences in rapid bone regen-
eration29,30. Particular concentrations of these ions, 60-80 g/mL and 16-50 g/mL of calcium and soluble 
silica, respectively, promote proliferation and differentiation of the mature osteoblast phenotypes, such as 
cell cycle regulators, apoptosis regulators, synthesis of DNA or growth factors28,53. The dissolution rates 
and apatite precipitation of these laser-engineered implants in physiological fluids remains analogous to 
that of the precursor glass, as shown in Fig. 3d. From these results, it is possible to predict the implant 
dissolution rate as a function of the precursor composition and thus to design and fabricate BG implants 
with tailored resorbability in the spatial domain. Nevertheless, the high silica content required to achieve 
low resorption would lead to loss of the osteoconduction35. Therefore, bioactive implants made of BG 
particles would be more practical if combined with a dissimilar low-resorbability bioactive material. 
Thus, we present subsequently the application of this laser-processed BG as a covering layer for a CaP 
core implant to obtain a material showing gradual resorbability.
Inner Core-Outer Shell Coupling into a Gradually Resorbable Material. In order to create a 
transition between the highly resorbable BG surface and the CaP multiphasic core, we deposited BG 
layers on previously processed CaP implants. Once the inner core is completed by adding the last CaP 
layer, and the temperature of the material has decreased to 500 °C during the cooling process, the BG 
particles are sprayed on its surface using a secondary nozzle and laser irradiation is applied. Essentially, 
the consolidated CaP inner core becomes a substrate for the outer BG layers. Glass thicknesses from 
200 μ m to 500 μ m can be deposited in a single layer (Fig. 4a), but higher thicknesses can be achieved by 
stacking successive layers in a direction perpendicular to the surface.
Insofar as this region will be subjected to degradation by cells and physiological fluids, structural 
modifications and new chemical compounds formed at the interface can compromise the bioactivity of 
the implant. At the interface between CaP and the BG (see Fig. 4b), cation diffusion occurs to afford a 
chemically homogeneous band by the solid-state reaction of sodium and CaP. Calcium ions are released 
from the interface and sodium calcium phosphate (β -rhenanite) is formed; the presence of this com-
pound was demonstrated by micro-Raman (Fig. 4c and d) and FTIR spectroscopy (supplementary figure 
S1). The Raman and FTIR spectra obtained from the interface are in good agreement with the reported 
spectra for β -NaCaPO4. Lamellae were extracted using the focused ion beam (FIB) technique for trans-
mission electron microscopy analysis of the interface, as shown in Fig.  5. The selected area electron 
diffraction (SAED) patterns demonstrated the amorphous state of the glass just beside the interface and 
the crystallinity of the interface. The obtained inter-planar distances confirm the presence of interfacial 
β -rhenanite. The coupling of amorphous and crystalline structural arrangements within the processed 
bioceramic implants is schematically represented in Fig. 6a. During a potential surgical implantation, the 
implant would be placed after resection of the damaged bone. To optimize the implant response, highly 
reactive BG must be immediately accessible by the healthy tissue of the implant site boundaries. On the 
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Figure 3. Validation of the outer shell material. (a) Layered bioceramic implant produced by rapid 
prototyping based on laser cladding of S520 BG from a three-dimensional CAD model of a left orbital rim 
implant. b) SEM micrographs showing the attachment and spreading of MC3T3-E1 cell line (A 1 day, B 
3 days, C 7 days). (c) Cell coverage of the sample surface after 3 and 7 days of incubation time (statistical 
significance p < 0.05). (d) Ion concentration after different times of immersion in 0.05 M Tris-HCl buffer for 
laser engineered 45S5 and S520 BG samples.
www.nature.com/scientificreports/
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contrary, the CaP material located far from the boundaries has to enable the new bone ingrowth without 
losing the implant stability. The control of the BG layer thickness is required to fulfill this function, in 
addition to avoid formation of harmful or less bioactive compounds at the interface with the CaP core. 
In this work, the connection between the highly reactive silicate based glass and a more stable phosphate 
monoclinic structure is provided through the orthorhombic crystal lattice of a gradually substituted 
β -rhenanite, formed by the solid-state reaction between α -TCP, TTCP, and Na+ from the coating.
The interconnecting β -rhenanite phase is a biocompatible and resorbable material that stimulates 
bone growth. The expression of cellular proliferation osteogenic markers in the presence of β -rhenanite 
was found to be higher than that in the presence of β -tricalcium phosphate. Granular bone substitutes 
containing β -rhenanite are approved as bone defect fillers for clinical use and are available on the mar-
ket54–56. On the contrary, while apatite formation in simulated body fluid is reported for other inter-
mediate compounds formed by thermal processing of silica glass and CaP, such as Ca5(PO4)2SiO4 and 
Na3Ca6(PO4)5, no experimental evidence of biocompatibility has been demonstrated through cytotoxicity 
assessments. With our technique, the formation of such additional phosphate phases at the interface is 
prevented by the absence of oxyapatite on the surface of the CaP core (see Fig. 2a). In the laser-processed 
implants presented here, the likelihood of silicate ion diffusion beyond the interface is minimal. The 
laser power density and associated sodium diffusion are limited to avoid the possibility of Na3Ca6(PO4)5 
formation by a reaction of the oxyapatite grains present underneath the CaP core surface. Therefore, a 
suitable biological response is to be expected; the β -rhenanite compound formed at the interface between 
the CaP core and the BG outer layer does not compromise the bioactivity of the laser-processed implant.
The structural changes of the BG outer shell were measured after the process by sequential micro-Raman 
spectra acquisition at different distances from the interface. The network connectivity is strongly related 
to the glass bioactivity57, glasses with high network connectivity (greater than 2.4) are characterized by 
low degradability and an inert biological response, while highly disrupted networks result in faster dis-
solution. We observed that the glass structure is remarkably more open in regions close to the interface 
zone, which means that no passivation layer is produced at this point. The glass structure closes from 
Figure 4. Elemental composition and linear scanning of Raman shift spectra at the interface between the 
CaP core and the S520 BG outer layer. (a) Cross-sectional SEM overview of the outer S520 BG cover. (b) 
Elemental composition obtained by energy dispersive X-ray spectroscopy (EDS) microanalysis across the 
interface zone. (c) and (d) Raman spectra across the interface zone.
www.nature.com/scientificreports/
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the interface outwards, reaching the precursor glass structure connectivity at a few micrometers from 
the interface. Due to the low crystallization tendency of the S520 BG, from this point near the interface 
to the surface, the Raman spectra are identical to that of the precursor material and, therefore, the glass 
structure and its reactivity is consistent with the employed precursor glass.
The mechanical properties of these laser engineered implants enable their use in low-load-bearing 
applications. The compressive strength, 359 ± 51 MPa, is well above the cortical bone compressive 
strength35. The hardness of the bioactive glass outer layer and CaP core, 454 ± 30 and 443 ± 19 HV, and 
the fracture toughness KIC 0.91 ± 0.13 and 1.29 ± 0.17 MPa·m1/2, respectively, match the reported values 
for bioactive glasses and CaP sound ceramics35,58.
Owing to the sequential processing of CaP and BG layers by rapid prototyping based on laser clad-
ding, we obtained unique implant materials comprising a multiphasic CaP core surrounded by a BG 
covering. According to the degradability tests in physiological media, the BG external layers are expected 
to present high in vivo reactivity, adequate to the bone growth rates at early implantation times, while 
the multiphasic CaP core provides lower degradability rates and guarantees implant function in the long 
term (see Fig.  6b). The amount of each material in the implant can be tailored, thus allowing adapta-
tion of the resorption and osteoconduction levels at each location within the implant and improving 
its gradual substitution by newly formed bone. Moreover, the particle injection characteristics allows 
enhancement of the surface with specific features of biological relevance, for instance antibacterial or 
angiogenic activity, by means of incorporation of additional particles such as Ag2O, ZnO, Co3O4, or SrO.
Conclusion
We demonstrated the feasibility of producing unique implants for low-load-bearing bone repair through 
the application of rapid prototyping based on laser cladding using CaP and BG particles. The processing 
Figure 5. TEM analysis of the interface between the CaP inner core and outer BG layer. (Upper center) 
SEM micrograph showing the area removed by FIB technique and the remaining lamella between the 
interface and the deposited glass. (Lower center) Transmission electron micrograph of the lamellae 
center showing the crystalline-amorphous border. (Lower left) The SAED of the interface revealing the 
characteristic diffraction pattern of β -rhenanite (β -NaCaPO4). (Lower right) The SAED of the very near BG 
to the interface confirms the amorphous state.
www.nature.com/scientificreports/
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Figure 6. Schematic illustration of the structural arrangement in the patient-tailored bioceramic implant, 
and calcium release profile of surface and inner core. (a) The implant surface just neighboring the trepanned 
bone edge comprises a disordered silicate tetrahedral network, opened by an elevated concentration of 
modifier cations. The highly reactive BG structure is smoothly connected to the less-reactive multiphasic 
monoclinic arrangement of phosphate tetrahedrons and Ca2+ cations through an orthorhombic crystal 
lattice with decreasing presence of Na+ cations. (b) Ca2+ release profile in Tris-HCl buffer for HA precursor 
material, bare multiphasic CaP before laser cladding with BG, and of samples with S520 BG outer layers.
www.nature.com/scientificreports/
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method is characterized by the use of a high power laser beam for the production of a self-sustained 
molten material, without moulds, additives, or post-processing requirements. The implants are character-
ized by a tailored distribution of low-resorbability multiphasic CaP at the core and a highly reactive BG at 
the surface, which are connected through the formation of a bioactive sodium calcium phosphate inter-
face. The bioactivity and degradation rates of the BG precursor particles are preserved after deposition 
of the external layers. The versatility of this type of implant opens the door to a number of applications, 
such as the in vivo investigations to determine the optimum section and proportions of CaP and BG 
necessary to match the new bone ingrowth rate for each particular case.
Experimental Section
Synthesis of bioactive glass particles. High-purity reagents (Sigma-Aldrich) were used to syn-
thesize bioactive glasses with compositions equivalent to those of 45S5 bioactive glass (46.1 SiO2, 26.9 
CaO, 24.4 Na2O, 2.6 P2O5; molar %) and S520 bioactive glass (52.0 SiO2, 18.0 CaO, 20.9 Na2O, 2.0 P2O5, 
7.1 K2O; molar %). The precursor mixtures were subjected to melting (1.5 h at 1400 °C) and subsequent 
refining for 1 h in a Pt crucible. The glass melts were rapidly quenched in de-ionized water and subse-
quently dried. The obtained glass frits were ground and sieved between 100 μ m and 250 μ m in order to 
improve flowability through the gas–solid phase injector.
Synthesis of multiphasic calcium phosphate core. Crystalline calcium hydroxyapatite particles 
(Captal 90 Plasma-Biotal) were injected by means of an Ar (Argon-50 Praxair) conveying stream and 
a gas–solid injector coupled to a sealed hopper. The employed disposable substrates were preheated to 
200 °C during processing. An additional Ar gas stream was injected surrounding the interaction zone to 
avoid substrate oxidation during the initial steps of the process. At the point where the particles impinge 
on the substrate, a near-infrared laser beam (wavelength λ = 1064 nm, high-power Nd:YAG laser, Rofin) 
was focused by means of an aberration-corrected doublet lens (focal length: 80 mm). The calcium phos-
phate part was created by controlling the three-dimensional relative movement between the working 
head and the substrate. The HA mass flow rate was kept constant at 15 mg/s with a volumetric flow 
of carrying gas equal to 2.0 L/min and protective inert gas of 10 L/min. The processing energy density 
(P/vD, where P is the laser optical power, v is the scanning speed, and D is the laser beam diameter) was 
varied between 120 and 150 J/mm2. The relative temperature of the surface during cooling was recorded 
by means of a pyrometer; the cooling speed was maintained at approximately 100 °C/min. The profile 
of the processed part after depositing each layer was monitored by means of a CCD camera in order to 
maintain the geometrical configuration between the laser beam, the powder stream, and the processed 
part.
Coating with bioactive glass. After depositing the last superimposed strip, the calcium phosphate 
core is rotated to the required position for coating with the bioactive glass. The bioactive glass particles 
are injected in the interaction zone by means of a second injector. In this step of the process, the succes-
sively deposited bioactive glass strips are not superimposed, but overlapped to produce a bi-dimensional 
coating. The laser beam and the powder stream is defocused in this second configuration to cover a higher 
surface area; the bioactive glass mass flow was kept constant at 20 mg/s. A value of 45 J/mm2 was selected 
for the processing energy density of the near-infrared laser beam (wavelength λ = 1064 nm) for bioac-
tive glass thicknesses under 500 μ m. For thicknesses above 500 μ m, a longer wavelength λ = 10600 nm 
(high-power CO2 laser, Rofin) was employed to increase the energy coupling to the silicate glass network; 
this laser source was operated at an energy density of 25 J/mm2. The volumetric flow of carrying gas was 
equal to 1.0 L/min and a reduced protective gas flow of 2.0 L/min was employed.
Immersion test in Tris-buffer. Processed samples were placed in separate plastic containers with 
150 mL of 0.05 M Tris-HCl buffer (Tris(hydroxyl)methyl-aminomethane-HCl) of pH 7.4 at 36.5 °C 
(standard ISO10993-14). A sample surface area-to-buffer solution ratio of 0.015 cm2/mL was employed. 
Immersed samples and the solution were kept at 36.5 °C under stirring. At each of the following time 
periods, one 6-mL aliquot of solution was taken: 0.5, 1, 3, 6, 10, 24, 48, 72, 168, 336, and 504 h. Control 
samples of only 0.05 M Tris-HCl buffer were used to discard any influence of the test process in the 
final results. In addition, precursor 45S5 bioactive glass cast samples with the same dimensions as the 
laser-processed samples were tested for comparison purposes. Ten replicas of each different material 
were tested. Each solution was filtered through sterile filters to remove solids from the liquid and centri-
fuged to ensure separation of any residual solid. Spectroscopic elemental analyses were performed with 
inductively coupled plasma–optical emission spectroscopy (ICP-OES, Perkin Elmer Optima 4300 DV). 
Calibration for Ca, Si, P, Na, and K analyses were performed with 10-mg/L standards with RSD values 
below 2.0%.
Cell culture. The biological performance of the material was assessed by using the pre-osteoblastic cell 
line MC3T3-E1. This cell line has been established from C57BL/6 mouse calvaria, and was obtained from 
the European Collection of Cell Cultures (ECACC, UK). The cells were cultured in MEM-alpha (Sigma, 
USA) supplemented with 10% fetal bovine serum (FBS; Invitrogen, USA) and were maintained at 37 °C 
in a humidified atmosphere with 5% CO2. Laser-cladding-processed samples with an area of 10 × 10 mm2 
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were cleaned in an ultrasound bath with ethanol and acetone, followed by air drying inside a laminar 
flow chamber. Subsequently, the samples were autoclaved for 15 min at 121 °C.
In vitro cytotoxicity. The cytotoxicity of the material was determined in a non-direct-contact 
cells-material assay by means of the solvent extraction test, according to the EN ISO 10993-5 and 10993-
12 standards. This test consists of cell seeding over the solvent extracts obtained previously. The solvent 
extraction was carried out by placing the sterilized processed samples on a rotating mixer for 24 h in 
MEM-alpha supplemented with FBS at 37 °C. The extracts were diluted with MEM-alpha to obtain 100%, 
50%, 30%, 10%, and 5% of the original concentration. The same procedure was followed with phenol 
solution at a concentration of 6.4 g/L in MEM-alpha as the positive control. Pure MEM-alpha was used as 
negative control. MC3T3-E1 cells were cultured for 24 h in 96-well tissue culture plates at a concentration 
of 1.7 × 105 cells/mL. Cellular activity was quantified with the Cell Proliferation Kit I (MTT) from Roche 
Molecular Biochemicals. This colorimetric assay is based on the reduction of the yellow tetrazolium 
salt MTT (3-(4,5-dimethyltyazolyl-2)-2,5-diphenyl tetrazolium bromide) into insoluble purple formazan 
crystals by the mitochondrial enzyme succinate dehydrogenase, only present in living cells. Data analy-
sis was performed using one-way analysis of variance, Tukey post hoc test (SPSS), p-values < 0.05 were 
considered statistically significant. Data are presented as mean ± standard deviation (n = 10). Error bars 
in figures represent standard deviations.”
Cell morphology and adhesion. Cell adhesion and morphology was assessed in a direct-contact 
cells-material assay. Sterilized samples were placed in 24-well tissue cultured plates. An MC3T3-E1 sus-
pension of 2.5 × 104 cells/mL in 1 mL of MEM-alpha supplemented with 10% FBS was added to each 
well, and the culture medium was renewed every 2–3 days. Cell seeding was carried out directly over 
the modified surface, which was the section analyzed. After each incubation time (1, 3, and 7 days), ten 
replicates of each experiment were prepared for analysis by scanning electron microscopy: In brief, the 
surfaces were fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer at pH 7.4 for 2 h at 4 °C. Samples 
were then washed three times for 30 min each with 0.1 M cacodylate buffer and dehydrated in graded 
ethanol solutions (30%, 50%, 70%, 80%, and 95%) for 30 min in each solution and in absolute etha-
nol for 1 h. After the dehydration, samples were subjected to an increasing amylacetate/ethanol mixture 
(25:75, 50:50, and 75:25 for 15 min each) and to pure amylacetate twice for 15 min. The critical point 
of CO2, at 75 atm and 31.3 °C was the final step. The samples were finally mounted on metal stubs and 
sputter-coated with gold prior to observation by scanning electron microscopy.
Mechanical properties. The compressive strength was determined by crushing eight CaP-BG cylin-
drical samples (diameter 8 mm) in dry conditions using an axial testing machine equipped with a 50 kN 
load cell and applying a ramp rate of 0.1 mm/min. The Vickers microhardness HV0.5 was measured by 
a microhardness testing machine, applying a load of 4.903 N during a period of 15 s to the bioactive 
glass surface and to the CaP core cross-section, respectively. The fracture toughness KIC was evaluated, 
just after indentation, from the well-developed radial cracks58. A value of 95 GPa was employed for the 
Young’s modulus for the CaP inner core and 78 GPa for the bioactive glass outer layer.
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